Validating the Time-Use Algorithm To Estimate Productivity Loss in Persons With Multiple Sclerosis

Author(s)

Fox J1, Mearns ES2, Majda T2, Rosettie KL2, Win N2, Kowal S3
1CHOICE Institute, University of Washington, Seattle, WA, USA, 2Genentech, Inc., South San Francisco, CA, USA, 3Genentech, Inc., Alameda, CA, USA

OBJECTIVES: Productivity loss is an imperative societal cost to consider but is also one that is under researched and quantified. The Institute for Clinical and Economic Review will be using a proxy productivity algorithm (Jiao and Basu, 2023) to estimate and incorporate productivity loss into future value assessments when direct data are lacking. The productivity algorithm estimates changes in productivity based on national trends in quality of life, but it has not yet been validated. We compare market productivity loss estimates generated by the algorithm with empiric estimates from real-world evidence.

METHODS: We used a US employment survey of 3870 persons with multiple sclerosis and estimated productivity loss across severity, as measured by Expanded Disability Status Scale (EDSS) score. We leveraged the reported ages in the survey dataset and produced proxy estimates using the productivity algorithm. Estimates were compared by percent and absolute difference.

RESULTS: Survey results showed market productivity loss associated with EDSS scores of 0 to 9, ranging from $1754 to $50,480, respectively. The productivity algorithm generated a range of $0 to $66,999, respectively. Overall, the percent difference in these findings ranged from −91.57% to 100%. The average difference across all EDSS scores was 5.03%, and differences were wider at the ends of the severity spectrum vs the middle.

CONCLUSIONS: The productivity algorithm allows for inclusion of productivity loss costs when major data gaps exist, thereby allowing for more routine use of societal perspective in cost-effectiveness analyses. It produced, on average, only marginally different estimates that were generated from a disease-specific survey. However, additional research is needed to understand the impact of observed differences across severity levels when estimating the lifetime burden of productivity losses in value assessment.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

MSR8

Topic

Economic Evaluation, Methodological & Statistical Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics, Novel & Social Elements of Value, Work & Home Productivity - Indirect Costs

Disease

Neurological Disorders, No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×